Marken Meets Critical Demand For In Vitro Lab Shipments
Marken is experiencing significant growth in demand for their specialized handling and shipments of biopsied embryo cells to laboratories across the US. These cells are often used in Pre-Implantation Genetic Diagnostic Testing (PGD) and to diagnose certain diseases and conditions during in vitro fertilization (IVF) treatments.
WHITE PAPERS & CASE STUDIES
Clinical Trial Logistics In Africa: Ensuring Quality, Compliance And Control
Today’s Africa has increasingly become a source of fascination for pharmaceutical researchers drawn to the study and control of both communicable diseases such as malaria, tuberculosis and HIV/AIDS as well as diseases of the developed world like cancer, diabetes, hypertension and chronic respiratory disease. By World Courier
Despite An Airport Strike, Marken Preserves The Data Chain
Marken collected a shipment from southern Sweden that was bound for next-day delivery in northern Belgium. However, all airline flights into Belgium were cancelled as a result of a strike action by airport workers.
A 15-Minute Guide To Clinical Trial Document Management And The eTMF
At the Drug Industry Association’s (DIA) annual meeting held in June 2012, the TMF Reference Model Working Group released TMF reference model 2.0, which included significant updates from the group’s 2010, 1.0 release.
Improve Accuracy And Efficiency In Data Collection For Mental-Health Evaluations And Assessments
MedAvante is a global provider of centralized, expert psychological rating services to the pharmaceutical, biotechnology, and medical device industries.
Marken Delivers In Spite Of A Dry Ice Disruption In Moscow
In August of 2010, both dry ice factories in Moscow, Russia were shut down for an unplanned technical upgrade. At the same time the weather in the region was unusually hot (40°C, 104°F) which placed a higher than normal demand for dry ice to keep frozen shipments within the required temperature range.
Medical Device Companies Turning To New Breed Of Supply Chain Partner
Medical Device companies are well aware of the strategic and operational impact of tougher reimbursement policies and the soon to be implemented medical device tax.